VERAPAMIL HYDROCHLORIDE
- Product NDC
- 50090-7311
- 11-digit product format
- 500907311
- Labeler code
- 50090
- Product ID
- 50090-7311_6affb2d0-1b92-4ac8-80fa-cac7807a60a3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VERAPAMIL HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA206173
- Marketing category
- ANDA
- Marketing start
- 2023-01-02
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7311-1 | 50090731101 | 90 TABLET in 1 BOTTLE (50090-7311-1) | 90 tablet | 2024-10-14 | No | No | Historical |